Commercial Decision Guide
Purpose
This page helps executive sponsors and finance/operations stakeholders decide how to buy Nova with controlled risk.
Buying options
| Option | Best when | What you commit now | Decision output |
|---|---|---|---|
| 6-week Windows-first POC | You need fast proof and executive hands-on visibility | Limited scope, clear KPI baseline, executive sponsor | Go/no-go decision with evidence + 6-month trial activation |
| Phase rollout (Nexus first) | POC value is proven and speed is the top priority | One application area and delivery cadence | Measurable cycle-time and reliability improvement |
| Multi-phase modernization | You want broader economics (cost + speed + integration) | Sequenced roadmap and governance model | 12-24 month transformation plan |
Budget logic for executives
- Phase funding by evidence, not by long-range assumptions
- Cap downside risk at each decision gate
- Expand only when KPI and governance confidence are proven
Commercial principles
- No big-bang lock-in commitment upfront
- Existing Ingenium logic and IP remain under your ownership
- Commercial model can be structured as fixed-scope milestones or time-and-material, based on procurement preference
- Scope-based milestones tied to decision gates
- Transparent assumptions for cost, timeline, and dependencies
What to align before approval
- Priority Ingenium flow for the first scope
- Baseline metrics (current build/deploy time, manual effort, rollback rate)
- Sponsor group (technology sponsor, business owner, finance delegate)
- Gate criteria for phase expansion
Decision timeline (typical)
Trial-to-production conversion path
Conversion gate criteria
- KPI trend remains positive versus baseline (cycle time, reliability, manual effort)
- Governance controls are operating (traceability, risk log, owner accountability)
- Commercial scope, ownership model, and rollout plan are approved
Executive takeaway
Nova is purchased as a controlled modernization sequence, not as a single all-or-nothing programme.